GENOMICS
Diabetes Endocrinol. 2022;10(8):597-608. doi:10.1016/S2213-8587(22)00159-0
6 Giwa AM, Ahmed R, Omidian Z et al. Current understandings of the pathogenesis of type 1 diabetes: Genetics to environment. World J Diabetes. 2020; 11(1):13-25. doi:10.4239/wjd.v11.i1.13
7 Holt RIG, DeVries JH, Hess-Fischl A et al. The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2021;44(11):2589-2625. doi:10.2337/ dci21-0043
8 Echeverri A, Tobón G. Autoimmune diabetes mellitus (Type 1A). In: Autoimmunity: From Bench to Bedside. El Rosario University Press, 2013.
9 Luckett AM, Weedon MN, Hawkes G et al. Utility of genetic risk scores in type 1 diabetes. Diabetologia. 2023;66(9):1589- 1600. doi:10.1007/s00125-023-05955-y
10 Kondrashova A, Reunanen A, Romanov A et al. A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland. Ann Med. 2005;37(1):67-72. doi:10.1080/07853890410018952
11 Diabetes UK. Research spotlight - what causes type 1 diabetes? (Diabetes UK, 2023)
https://www.diabetes.org.uk/our- research/about-our-research/hot-topics/ what-causes-type-1
12 Wray NR, Goddard ME. Multi-locus models of genetic risk of disease. Genome Med. 2010;2(2):10. doi:10.1186/gm131
13 Oram RA, Patel K, Hill A et al. A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults. Diabetes Care. 2016;39(3):337-344. doi:10.2337/dc15- 1111
14 Abraham G, Kowalczyk A, Zobel J, Inouye M. Performance and Robustness of Penalized and Unpenalized Methods for Genetic Prediction of Complex Human Disease. Genet Epidemiol. 2013;37(2):184- 195. doi:10.1002/gepi.21698
15 Sharp SA, Weedon MN, Hagopian WA, Oram RA. Clinical and research uses of genetic risk scores in type 1 diabetes. Curr Opin Genet Dev. 2018;50:96-102. doi:10.1016/
j.gde.2018.03.009
16 Redondo MJ, Geyer S, Steck AK et al. A Type 1 Diabetes Genetic Risk Score Predicts Progression of Islet Autoimmunity and Development of Type 1 Diabetes in Individuals at Risk. Diabetes Care. 2018; 41(9):1887-1894. doi:10.2337/dc18-0087
17 Sharp SA, Rich SS, Wood AR et al. Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis. Diabetes Care. 2019; 42(2):200-207. doi:10.2337/dc18-1785
18 Thakkar S, Chopra A, Nagendra L, Kalra S, Bhattacharya S. Teplizumab in
Correct classification is essential to ensure correct treatment strategies are implemented which will in turn help to reduce the complications associated with diabetes.
Type 1 Diabetes Mellitus: An Updated Review. touchREVIEWS in Endocrinology. 2023;19(2):7. doi:10.17925/EE.2023.19.2.7
19 Herold KC, Gitelman SE, Gottlieb PA et al. Teplizumab: A Disease-Modifying Therapy for Type 1 Diabetes That Preserves β-Cell Function. Diabetes Care. 2023;46(10):1848-1856. doi:10.2337/dc23- 0675
20 Phelps NH, Singleton RK, Zhou B et al. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population- representative studies with 222 million children, adolescents, and adults. Lancet. 2024;403(10431):1027-1050. doi:10.1016/ S0140-6736(23)02750-2
21 Diabetes UK. Differences between Type 1 and Type 2 Diabetes. (Diabetes UK, 2023)
https://www.diabetes.org.uk/diabetes-the- basics/differences-between-type-1-and- type-2-diabetes
22 The Lancet Regional Health – Europe. Misdiagnosis of type 1 and type 2 diabetes in adults. Lancet Reg Health Eur. 2023 Jun 2;29:100661. doi:10.1016/j. lanepe.2023.100661
23 Dhatariya K. Blood Ketones: Measurement, Interpretation, Limitations, and Utility in the Management of Diabetic Ketoacidosis. The Review of Diabetic Studies. 2016;13(4):217-225. doi:10.1900/ RDS.2016.13.217
24 Riddle MC, Philipson LH, Rich SS et al. Monogenic Diabetes: From Genetic Insights to Population-Based Precision in Care. Reflections From a Diabetes Care Editors’ Expert Forum. Diabetes Care. 2020;43(12):3117-3128. doi:10.2337/ dci20-0065
25 Owen KR. Monogenic diabetes: old and new approaches to diagnosis. Clin
WWW.PATHOLOGYINPRACTICE.COM OCTOBER 2024
Med (Lond). 2013 Jun;13(3):278-281. doi:10.7861/clinmedicine.13-3-278
26 Patel KA, Oram RA, Flanagan SE et al. Type 1 Diabetes Genetic Risk Score: A Novel Tool to Discriminate Monogenic and Type 1 Diabetes. Diabetes. 2016; 65(7):2094-2099. doi:10.2337/db15-1690
27 Diabetes UK. How Many People in the UK have Diabetes? (Diabetes UK, 2023)
https://www.diabetes.org.uk/about-us/ about-the-charity/our-strategy/statistics
28 Harrison JW, Tallapragada DSP, Baptist A et al. Type 1 diabetes genetic risk score is discriminative of diabetes in non- Europeans: evidence from a study in India. Sci Rep. 2020;10(1):9450. doi:10.1038/ s41598-020-65317-1
29 Oram RA, Sharp SA, Pihoker C et al. Utility of Diabetes Type–Specific Genetic Risk Scores for the Classification of Diabetes Type Among Multiethnic Youth. Diabetes Care. 2022;45(5):1124-1131. doi:10.2337/ dc20-2872
Jason Armstrong BSc is Scientific Content Creator at Randox Laboratories. After achieving his degree in Biochemistry and beginning his career in an R&D laboratory, he
made the switch to pursue his passion in scientific communications. Jason has a background in the research and development of immunology, clinical chemistry and food diagnostic assays giving him an insight into the workings of a laboratory and what is required of an efficient and successful medical laboratory.
Randox
+44 28 94422413
www.randox.com
45
AdobeStock / Four_Lakes
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
